Trial description
A randomised phase III trial to evaluate the duration of anti-PD1 monoclonal antibody treatment in patients with metastatic melanoma
Contact name
Dr Pippa Corrie
Trial start date
Friday, September 21, 2018
Trial end date
Friday, March 31, 2023
Trial tumour type
Skin & melanoma
Show on Radiotherapy